Product Images Eliquis

This is a table with data related to the effectiveness and safety of Apixaban and Warfarin for different subgroups of patients. The table includes the number of events and number of patients in different categories, as well as the hazard ratio (HR) for Apixaban versus Warfarin, representing the risk of an event occurring in patients treated with Apixaban compared to those treated with Warfarin. The table also includes the confidence interval (CI) for the HR. There are subgroups based on weight, age, gender, prior stroke or transient ischemic attack, diabetes mellitus, CHADS2 score, creatinine clearance, geographic region, and randomization status. The table suggests that Apixaban may be more effective and safer than Warfarin in many subgroups of patients. Further analysis may be necessary to confirm these findings.*

This is a population description table that includes information on end-stage renal disease and renal impairment (mild, moderate and severe) in individuals aged between 18-40 years and individuals with a body weight of 65-85 kg or less than 50 kg. The table also contains information on hepatic impairment and dose adjustment recommendations. However, it is not clear what type of medication or treatment this table is referring to.*

This is a product with the code number 9933-0 and the name or brand "LoF' ELTQUIS". The product has 5 mg of a substance called "APTXABAN". It comes with 60 tablets and should be stored at 6870 7 degrees Celsius.*